Jacqueline Tuton
Psychiatric/Mental Health · Las Cruces, NMNPI 1669915690
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 39.3% of the total. Reporting peaked in 2024 at $6,277 and has fallen 76.2% since, to $1,492 in 2025. Among psychiatric/mental health clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $54.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$4K
- Inspire Medical Systems, Inc.$3K
- ZOLL Respicardia, Inc.$2K
- Harmony Biosciences LLC$786
- Vanda Pharmaceuticals Inc.$476
- Teva Pharmaceuticals USA, Inc.$247
- plus $531 from 8 others
What the payments were for
- Consulting fees$1501%
- Speaking & faculty fees$2,36523%
- Travel & lodging$3,02929%
- Food & beverage$4,64544%
- Education$2793%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 22 | $4,118 |
| Inspire Medical Systems, Inc. | 84 | $2,717 |
| ZOLL Respicardia, Inc. | 2 | $1,594 |
| Harmony Biosciences LLC | 27 | $786 |
| Vanda Pharmaceuticals Inc. | 21 | $476 |
| Teva Pharmaceuticals USA, Inc. | 11 | $247 |
| Axsome Therapeutics, Inc. | 8 | $171 |
| AbbVie | 7 | $115 |
| Idorsia Pharmaceuticals US Inc | 3 | $81 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $41 |
| Alpha Cognition USA, Inc. | 1 | $37 |
| Neurocrine Biosciences, Inc. | 2 | $35 |
| Merck | 2 | $30 |
| Lilly USA, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$3,530
- remede System$1,594
- Inspire$1,083
- Fanapt$220
- Inspire Upper Airway Stimulation System$176
- XYREM$150
How this compares
$10,468 in reported general payments places this provider in the 95th percentile of 228 psychiatric/mental health providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| WakixPitolisant Hcl | 27 | $305,090 |
| SunosiSolriamfetol Hcl | 16 | $22,546 |
| VraylarCariprazine Hcl | 13 | $18,104 |
| Lurasidone Hcl | 14 | $16,001 |
| BelsomraSuvorexant | 27 | $14,364 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 67 | $3,594 |
| Doxepin Hcl | 57 | $2,471 |
| Temazepam | 17 | $1,433 |
| Modafinil | 19 | $1,185 |
| Ropinirole Hcl | 71 | $1,095 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 18 | $1,050 |
| Trazodone Hcl | 75 | $911 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 45 | $821 |
| Clonazepam | 60 | $750 |
| Armodafinil | 18 | $589 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $786 | $305,09027 claims |
| Axsome Therapeutics, Inc.Sunosi | $171 | $22,54616 claims |
| AbbVieVraylar | $115 | $18,10413 claims |
| MerckBelsomra | $30 | $14,36427 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 228 psychiatric/mental health providers in New Mexico.
Other psychiatric/mental health in Las Cruces
- Mario HerreraLas Cruces$7K
- Heidi PattarozziLas Cruces$6K
- Lorena GarciaLas Cruces$6K
- Jacquelyn WilliamsLas Cruces$4K
- Selene MendozaLas Cruces$4K
- Fernando GuillenLas Cruces$4K
- Claudia RuizLas Cruces$4K
- Karen LeeLas Cruces$3K
- Deanna Joy MynattLas Cruces$3K
- Maria MendozaLas Cruces$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.